Additionally, with the Federal Government considering the possibility of connecting the axis to the National Rail network ...

The Lagos State Government will today commence full enforcement of a technology-driven electronic call-up (e-call-up) system ...

The Independent Marketers Association of Nigeria, South-West Zone, has directed its members to boycott the Lekki-Epe corridor from Monday to avoid embarrassment.The chairman of the zone, Chief Oyewole ...

Although the traffic situation has been improving slightly in recent years, when it does hit, it takes over the entire city.

Mumbai: Ichnos Glenmark Innovation (IGI), a joint venture between Glenmark Pharmaceuticals and Ichnos Sciences, on Monday shared promising results from an ongoing phase-1 trial of ISB 2001, a ...

Anna Skinner is a Newsweek senior reporter based in Indianapolis. Her focus is reporting on the climate, environment and weather but she also reports on other topics for the National News Team.

On June 1, Allogene Therapeutics Inc. (NASDAQ:ALLO) presented updated data from the Phase 1 TRAVERSE study of ALLO-316 in advanced or metastatic renal cell carcinoma/RCC during an oral ...

The Phase 1/2a study, AROALK7-1001, recently dosed its first participants. In addition to a single agent, the study will employ combination approaches using tirzepatide in obese individuals ...

ARO-ALK7 is the first investigational RNAi therapeutic to enter clinical studies that targets a gene expressed in adipose tissue Study initiation highlights Arrowhead’s leadership in the delivery of ...

The Lagos State Government has said the E-Call Up system on the Lekki-Epe Corridor will minimise traffic congestion in the area. The government also noted that enforcement of the call-up system ...

Several northern states in the U.S. might be able to see the northern lights on Sunday, June 1 and Monday, June 2, according to the National Oceanic and Atmospheric Administration. The northern ...

Bicara Therapeutics Inc. has announced promising data from its Phase 1/1b clinical trial of ficerafusp alfa, a novel bifunctional antibody, in combination with pembrolizumab for treating first ...